Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Health Systems, Economic Evaluations, Quality of Life, and Schizophrenia research and treatment.
Donanemab in Early Symptomatic Alzheimer Disease
Donanemab in Early Symptomatic Alzheimer’s Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
ENDPOINTS FOR PRE-DEMENTIA AD TRIALS: A REPORT FROM THE EU/US/CTAD TASK FORCE